Chengdu pregnant mothers must understand these issues regarding the storage of umbilical cord mesenchymal stem cells

The 2018 edition of "Cell Storage Industry Development Research Report" ahows that in developed countries, the storage rate of stem cells reaches 15-20%, while the storage rate in China is only 1%. However, in recent years, with the expansion of stem cell research projects, the publication of relevant research results, and the development and improvement of cell cryopreservation technology, more and more people in China choose to store stem cells. The storage projects mainly focus on neonatal_perinatal tissue. Stem cells are mainly stored, including umbilical cord mesenchymal stem cells and placental mesenchymal stem cells.

Although more and more people are backing up their lives, storing neonatal umbilical cord and placental mesenchymal stem cells. But for most of them, there are still many doubts about the storage of mesenchymal stem cells from the umbilical cord and placenta, such as storage conditions, storage prices, storage differences, and so on. Today, Chengdu Jinxin Boyue Biotechnology Co., Ltd. will provide concentrated answers to the common doubts of pregnant mothers.

• Question 1: What is the difference between storing umbilical cord blood and umbilical cord and placental mesenchymal stem cells?
  

The two sources are different: the umbilical cord blood is derived from the blood remaining in the placenta and umbilical cord after the umbilical cord is ligated and disconnected after childbirth; the umbilical cord and placental mesenchymal stem cells are derived from the Wharton's glue in the umbilical cord placenta tissue, which requires professional preparation in the later stage Personnel extraction and preparation.

The two are used differently: umbilical cord blood is mainly used to extract hematopoietic stem cells, and the use requires strict matching. In theory, single umbilical cord blood that meets the storage standards can only be used once for patients weighing 30 kg-50 kg; and newborn Children's umbilical cord and placental mesenchymal stem cells have the characteristics of low immunogenicity, high purity, and strong vitality. They can be used between three generations of family members without matching and can achieve multiple cell expansion and culture, reaching at least 5 clinical treatments frequency.

The two target diseases are different: cord blood is mainly for leukemia, platelet disease, red blood cell disease, and other blood system diseases; umbilical cord, placental mesenchymal stem cells in the repair of brain and spinal cord injury, islet cell repair, renal parenchymal repair, premature ovarian failure There are related researches on recovery and other aspects.

• Question 2: What are the requirements for storing umbilical cord and placental mesenchymal stem cells?
  

Pregnant women have no genetic diseases, such as malignant tumors, hereditary cancers, and schizophrenia; no general infectious diseases such as hepatitis B, hepatitis C, syphilis, AIDS, etc.

• Question 3: Are the storage of umbilical cord and placental mesenchymal stem cells harmful to mothers and babies?
  

The collection of the umbilical cord/placenta is carried out after the baby is delivered and the placenta, umbilical cord, and fetus are completely separated. It will not cause any harm to the maternal delivery process and the fetus, which is equivalent to a "waste recycling" process.

• Question 4: If it is twins, do you save one copy or two copies?
  

Twins are recommended to store different types of stem cells separately. For example, one can store placental stem cells and the other can store umbilical cord and placental mesenchymal stem cells. There is a difference between identical twins and fraternal twins. Twins cannot be judged as identical twins based on the same sex or the same placenta. Therefore, it is recommended that twins store stem cell products separately.

• Question 5: What is the significance of storing umbilical cord and placental mesenchymal stem cells?
  

(1) The collection of the umbilical cord must be carried out immediately after the newborn is delivered, which is a non-renewable biological resource;

(2) The number of mesenchymal stem cells derived from the umbilical cord is abundant, turning waste into treasure;

(3) Umbilical cord mesenchymal stem cells have broad application prospects in the field of disease treatment in the future, including a variety of refractory diseases that cannot be solved by traditional methods;

(4) The potential risk of using umbilical cord mesenchymal stem cells that are more closely related is;

(5) Low investment and high security, which can save a lot of money when it is urgently needed in the future.

The above are the most common doubts people have when storing stem cell products. Chengdu Jinxin Boyue Stem Cells said: Through the deep cryopreservation technology at -196℃, the long-term preservation of stem cells with broad clinical application prospects is indispensable whether it is used for beauty anti-aging or treatment of multi-system diseases in the future. Treasure resources have added a possibility to the future.